IL25 and neoplasm: In the CRC mouse model, the IL-25-ILC2 axis could activate type 2 immune response to shape the tumor microenvironment.The IL-25-ILC2 axis also promoted the immunosuppressive effect of myeloid-derived suppressor cells (MDSCs) on CD8+ T cells in the colon.